ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05162	Measles	9/22	120/7206	3.01918303444e-11
ko04217	Necroptosis	10/22	178/7206	3.28905890217e-11
ko04658	Th1 and Th2 cell differentiation	8/22	96/7206	2.02585994753e-10
ko04659	Th17 cell differentiation	8/22	106/7206	4.5276968572e-10
ko05168	Herpes simplex infection	9/22	182/7206	1.28708416634e-09
ko05167	Kaposi's sarcoma-associated herpesvirus infection	8/22	191/7206	4.89662558281e-08
ko04630	Jak-STAT signaling pathway	7/22	132/7206	8.00496677312e-08
ko05164	Influenza A	7/22	167/7206	4.02871849252e-07
ko05169	Epstein-Barr virus infection	7/22	206/7206	1.66870219469e-06
ko05321	Inflammatory bowel disease (IBD)	4/22	56/7206	2.15667161575e-05
ko05145	Toxoplasmosis	5/22	126/7206	3.13147959249e-05
ko04380	Osteoclast differentiation	5/22	134/7206	4.21340951744e-05
ko05160	Hepatitis C	5/22	153/7206	7.94863663551e-05
ko04621	NOD-like receptor signaling pathway	5/22	157/7206	8.98709599438e-05
ko05340	Primary immunodeficiency	3/22	30/7206	9.50783841534e-05
ko05161	Hepatitis B	5/22	173/7206	0.000142279450235
ko05166	HTLV-I infection	6/22	292/7206	0.000181076981822
ko04060	Cytokine-cytokine receptor interaction	5/22	191/7206	0.000226426268109
ko05203	Viral carcinogenesis	5/22	277/7206	0.00124385716445
ko05140	Leishmaniasis	3/22	75/7206	0.0014466524254
ko05330	Allograft rejection	2/22	24/7206	0.00235801607953
ko04064	NF-kappa B signaling pathway	3/22	96/7206	0.00293662311744
ko04650	Natural killer cell mediated cytotoxicity	3/22	97/7206	0.00302436464531
ko05320	Autoimmune thyroid disease	2/22	29/7206	0.00343679416801
ko05152	Tuberculosis	3/22	187/7206	0.0184205179411
ko05202	Transcriptional misregulation in cancer	3/22	188/7206	0.0186824094118
ko05212	Pancreatic cancer	2/22	83/7206	0.0260827281967
ko04151	PI3K-Akt signaling pathway	4/22	390/7206	0.0284637310052
ko04662	B cell receptor signaling pathway	2/22	88/7206	0.0290727034486
ko04620	Toll-like receptor signaling pathway	2/22	100/7206	0.0367776766474